Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Heatwave
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Coronavirus: 'Davai bhi, kadaai bhi,' Modi calls for sustained caution
India

Coronavirus: 'Davai bhi, kadaai bhi,' Modi calls for sustained caution

Coronavirus: 'Davai bhi, kadaai bhi,' Modi calls for sustained caution
Written by Siddhant Pandey
Dec 31, 2020, 06:09 pm 3 min read
Coronavirus: 'Davai bhi, kadaai bhi,' Modi calls for sustained caution

Prime Minister Narendra Modi on Thursday called for sustained caution against COVID-19, even as India looks forward to commencing its vaccination drive soon. Modi was speaking at the foundation stone laying ceremony for an All India Institute of Medical Sciences (AIIMS) in Gujarat's Rajkot. The statement comes as India is expected to approve a COVID-19 vaccine in the coming days.

Statement
'Dawai bhi, kadaai bhi' mantra for 2021, says Modi

Modi said, "Earlier, I had said, 'Dawai nahi toh dhilai nahi' (no carelessness until there is a medicine). Now, I am saying 'Dawai bhi aur kadaai bhi' (yes to medicine and yes to caution)," adding that this would be the mantra for 2021. "We are preparing to run the world's largest vaccination program in the next year," the PM added.

Vaccine
India reviews approval for potential vaccines

Three potential vaccines are under consideration for emergency approval by India's drug regulator: Pfizer-BioNTech's BNT162b2 or Tozinameran, Oxford University and AstraZeneca's Covishield, and Bharat Biotech's COVAXIN. Notably, Tozinameran has already been approved and rolled out in several countries, while AstraZeneca's shot was approved in the United Kingdom on Wednesday. An expert panel will review the applications on Covishield and COVAXIN on Friday.

Information
'Preparations for vaccination program in last stages'

"Preparations are in the last stages for the vaccination program against COVID-19. People will get vaccines manufactured in India," Modi said. Earlier this week, India completed a two-day dry run to test the end-to-end vaccine delivery processes.

Outbreak
Number of infections decreasing, says Modi

As of Thursday morning, India reported 1,02,66,674 COVID-19 cases, including 1,48,738 deaths, 2,57,656 active cases, and 98,60,280 recoveries. Modi said the number of infections is decreasing now, as he dedicated the last day of the year 2020 to all frontline workers for their continued service during the pandemic. "In the year 2021, we have to strengthen India's role in healthcare," he added.

Quote
Modi also warned people against rumors

Urging people to be mindful of rumor-mongering ahead of the vaccination drive, Modi said, "Different people for their personal gains or due to irresponsible behavior spread various rumors. Maybe rumors will be spread when vaccination begins, some have already begun." "Be careful about such rumors and as responsible citizens refrain from forwarding messages on social media without checking."

AIIMS
AIIMS in Rajkot to be ready by mid-2022

Rajkot's AIIMS has been allotted 201 acres of land and is likely to be completed by mid-2022. It will be built at an estimated cost of Rs. 1,195 crore. The 750-bed hospital will also have a 30-bed AAYUSH block. It will have 125 MBBS seats and 60 nursing seats. Modi said people will witness both "experience and expertise" of mass immunization at AIIMS.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Narendra Modi
Coronavirus
Serum Institute of India
COVAXIN
Covishield
Related
Latest
Maserati Cielo convertible to break cover on May 25
Maserati Cielo convertible to break cover on May 25 Auto
5 films that deal with postpartum depression
5 films that deal with postpartum depression Entertainment
French Open, Rafael Nadal vs Novak Djokovic: Rivalry in numbers
French Open, Rafael Nadal vs Novak Djokovic: Rivalry in numbers Sports
Statistical comparison of 'Big Titles' between Djokovic, Federer, and Nadal
Statistical comparison of 'Big Titles' between Djokovic, Federer, and Nadal Sports
Vivo S15 Pro announced with MediaTek Dimensity 8100 SoC
Vivo S15 Pro announced with MediaTek Dimensity 8100 SoC Technology
Narendra Modi
Union minister Ashwini Vaishnaw makes India's first 5G call
Union minister Ashwini Vaishnaw makes India's first 5G call Technology
Professor demands gun license from PM after Gyanvapi 'shivling' comments
Professor demands gun license from PM after Gyanvapi 'shivling' comments India
12 killed in salt factory wall collapse in Gujarat's Morbi
12 killed in salt factory wall collapse in Gujarat's Morbi India
Twitter executive summoned over 'no action' against Kunal Kamra's video
Twitter executive summoned over 'no action' against Kunal Kamra's video India
Centre eases ban on wheat export: Here are more details
Centre eases ban on wheat export: Here are more details Business
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
Serum Institute of India
India inching closer to launching its first dengue vaccine
India inching closer to launching its first dengue vaccine Technology
COVID-19 vaccine precautionary dose service charge capped at Rs. 150
COVID-19 vaccine precautionary dose service charge capped at Rs. 150 India
DCGI approves emergency use of Covovax in children above 12
DCGI approves emergency use of Covovax in children above 12 India
Govt panel okays phase-3 trials of Covovax as booster dose
Govt panel okays phase-3 trials of Covovax as booster dose India
Only faster COVID-19 vaccinations can end pandemic: Adar Poonawalla
Only faster COVID-19 vaccinations can end pandemic: Adar Poonawalla India
More News
COVAXIN
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
More News
Covishield
SII to launch COVID-19 vaccine for children in 6 months
SII to launch COVID-19 vaccine for children in 6 months India
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
COVID-19: India reports 9K+ infections; 477 more deaths
COVID-19: India reports 9K+ infections; 477 more deaths India
No quarantine for fully vaccinated Indians in UK from Monday
No quarantine for fully vaccinated Indians in UK from Monday India
Date of birth on Co-WIN certificates for passengers traveling abroad
Date of birth on Co-WIN certificates for passengers traveling abroad India
More News
Related
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN India
Expert panel says no to Covovax's children trials in India
Expert panel says no to Covovax's children trials in India India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022